Ketamine Completed Phase 2 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02078817Ketamine in Adolescents With Treatment-Resistant Depression
NCT01627782A Study of Ketamine in Patients With Treatment-resistant Depression